Home

Attovia Therapeutics, Inc.

CIK 2058707 · President and CEO · last filed 2026-08-06

Attovia Therapeutics, Inc. is a President and CEO who has filed 4 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for ATTO, was dated Aug 6, 2026. The firm reports its address in San Carlos, CA. 4 SEC filings were submitted jointly with GOLDMAN SACHS GROUP INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
1091 INDUSTRIAL ROAD
SAN CARLOS, CA 94070
Phone
(510) 399-5001
State of Incorporation
DE
Related Filers
GOLDMAN SACHS GROUP INC — 4 joint filings, latest 2026-08-28
Broad Street Principal Investments, L.L.C. — 3 joint filings, latest 2026-08-28
Deep Track Capital, LP — 3 joint filings, latest 2026-08-12
GOLDMAN SACHS & CO. LLC — 3 joint filings, latest 2026-08-28
COLIN WALSH — 3 joint filings, latest 2026-08-28
West Street Life Sciences I, L.P. — 3 joint filings, latest 2026-08-28
Hubert Chen — 2 joint filings, latest 2026-08-06
Deep Track Biotechnology Master Fund, Ltd. — 2 joint filings, latest 2026-08-10
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ATTO President and CEO — $25.55 — $0 4 2026-08-06

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-06 ATTO Grant (A) — $0 EDGAR
2026-08-06 ATTO Grant (A) — $0 EDGAR
2026-08-06 ATTO Grant (A) — $0 EDGAR
2026-08-06 ATTO Grant (A) — $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.